Exsanguination in trauma: a review of diagnostics and treatment options
LMG Geeraedts Jr, HAH Kaasjager, AB Van Vugt… - Injury, 2009 - Elsevier
Trauma patients with haemorrhagic shock who only transiently respond or do not respond
to fluid therapy and/or the administration of blood products have exsanguinating injuries. …
to fluid therapy and/or the administration of blood products have exsanguinating injuries. …
[HTML][HTML] Interventions for rapid recognition and treatment of sepsis in the emergency department: a narrative review
JW Uffen, JJ Oosterheert, VA Schweitzer… - Clinical Microbiology …, 2021 - Elsevier
Background Sepsis is a major cause of morbidity and mortality worldwide. Early recognition
and treatment of sepsis is associated with improved outcome. The emergency department (…
and treatment of sepsis is associated with improved outcome. The emergency department (…
Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial
N Alam, E Oskam, PM Stassen, P van Exter… - The Lancet …, 2018 - thelancet.com
Background Emergency medical services (EMS) personnel have already made substantial
contributions to improving care for patients with time-dependent illnesses, such as trauma …
contributions to improving care for patients with time-dependent illnesses, such as trauma …
Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial
JWP Vernooij, HAH Kaasjager, Y Van Der Graaf… - Bmj, 2012 - bmj.com
Objective To investigate whether an internet based, nurse led vascular risk factor management
programme promoting self management on top of usual care is more effective than usual …
programme promoting self management on top of usual care is more effective than usual …
One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomised controlled trial
Objective To study whether stopping elastic compression stockings (ECS) after 12 months is
non-inferior to continuing them for 24 months after proximal deep venous thrombosis. …
non-inferior to continuing them for 24 months after proximal deep venous thrombosis. …
[HTML][HTML] Inappropriate laboratory testing in internal medicine inpatients: prevalence, causes and interventions
BEL Vrijsen, CA Naaktgeboren, LM Vos… - Annals of Medicine and …, 2020 - Elsevier
Background To reduce overutilization of laboratory testing many interventions have been
tried, but selecting the most effective intervention for a given setting is challenging. To be …
tried, but selecting the most effective intervention for a given setting is challenging. To be …
[HTML][HTML] A simple decision rule including D‐dimer to reduce the need for computed tomography scanning in patients with suspected pulmonary embolism
J Van Es, LFM Beenen, RA Douma… - Journal of Thrombosis …, 2015 - Elsevier
Background An ‘unlikely’ clinical decision rule with a negative D‐dimer result safely
excludes pulmonary embolism (PE) in 30% of presenting patients. We aimed to simplify this …
excludes pulmonary embolism (PE) in 30% of presenting patients. We aimed to simplify this …
[HTML][HTML] Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes
M de Vries, F El-Morabit, KJ van Erpecum… - European journal of …, 2022 - Elsevier
Aims To compare NAFLD prevalence, distribution and its etiologic determinants in patients
with type 1 diabetes (T1D) and type 2 diabetes (T2D). Methods In this cross-sectional study, …
with type 1 diabetes (T1D) and type 2 diabetes (T2D). Methods In this cross-sectional study, …
[HTML][HTML] Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes
M de Vries, J Westerink, F El-Morabit… - Diabetes Research and …, 2022 - Elsevier
Aims Assess prevalence of hepatic steatosis (HS) and of fibrosis in an unselected population
of patients with type 1 diabetes. Describe their clinical profile and explore the association …
of patients with type 1 diabetes. Describe their clinical profile and explore the association …
Intra-gastric balloon with lifestyle modification: a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver …
AM Van Dijk, M De Vries, F El-Morabit, ST Bac… - Internal and emergency …, 2023 - Springer
Background Data on effects of intra-gastric balloon (IGB) on metabolic dysfunction-associated
steatotic liver disease (MASLD) are scarce, in part with contradictory results, and mainly …
steatotic liver disease (MASLD) are scarce, in part with contradictory results, and mainly …